tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

EOLS Stock Latest News

Evolus price target raised to $22 from $20 at Barclays
The FlyEvolus price target raised to $22 from $20 at Barclays
4d ago
EOLS
TikTok comes back online in U.S., Schwab reports Q4 beat: Morning Buzz
PremiumThe Fly
TikTok comes back online in U.S., Schwab reports Q4 beat: Morning Buzz
10d ago
GM
DHI
Evolus sees FY25 revenue $345M-$355M, consensus $347.37M
PremiumThe Fly
Evolus sees FY25 revenue $345M-$355M, consensus $347.37M
10d ago
EOLS
Evolus expects FDA approval for Evolysse within 90 days, ahead of schedule
PremiumThe Fly
Evolus expects FDA approval for Evolysse within 90 days, ahead of schedule
10d ago
EOLS
Evolus reports preliminary Q4 revenue $79M, consensus $77.23M
PremiumThe Fly
Evolus reports preliminary Q4 revenue $79M, consensus $77.23M
10d ago
EOLS
Evolus raises FY24 revenue view to $266.3M from $260M-$266M, consensus $264.21M
PremiumThe FlyEvolus raises FY24 revenue view to $266.3M from $260M-$266M, consensus $264.21M
10d ago
EOLS
Evolus, Inc. Reports Strong Q3 2024 Growth
Premium
Company Announcements
Evolus, Inc. Reports Strong Q3 2024 Growth
3M ago
EOLS
Evolus reports Q3 EPS (30c), consensus (10c)
Premium
The Fly
Evolus reports Q3 EPS (30c), consensus (10c)
3M ago
EOLS
Evolus sees FY24 revenue $260M-$266M, consensus $266.1M
PremiumThe Fly
Evolus sees FY24 revenue $260M-$266M, consensus $266.1M
3M ago
EOLS
Evolus says Estyme receives EU Medical Device Regulation certification
PremiumThe Fly
Evolus says Estyme receives EU Medical Device Regulation certification
3M ago
EOLS
Evolus rewards patient loyalty program surpasses 1M enrolled consumers
PremiumThe Fly
Evolus rewards patient loyalty program surpasses 1M enrolled consumers
3M ago
EOLS
3 Best Stocks to Buy Now, 9/13/2024, According to Top Analysts 
PremiumMarket News
3 Best Stocks to Buy Now, 9/13/2024, According to Top Analysts 
5M ago
DAL
AURA
Evolus price target raised to $20 from $16 at Barclays
PremiumThe FlyEvolus price target raised to $20 from $16 at Barclays
5M ago
EOLS
Evolus raises FY24 revenue to $260M-$270M from $255M-$265M, consensus $262.5M
Premium
The Fly
Evolus raises FY24 revenue to $260M-$270M from $255M-$265M, consensus $262.5M
6M ago
EOLS
Evolus reports Q2 non-GAAP operating income $1.1M vs. ($8.0M) last year
Premium
The Fly
Evolus reports Q2 non-GAAP operating income $1.1M vs. ($8.0M) last year
6M ago
EOLS
Evolus expands global footprint with debut of Nuceiva in Australia
PremiumThe Fly
Evolus expands global footprint with debut of Nuceiva in Australia
6M ago
EOLS
Evolus (EOLS) Is Capturing the Aesthetic Market with a Flagship Product
PremiumMarket News
Evolus (EOLS) Is Capturing the Aesthetic Market with a Flagship Product
6M ago
EOLS
Evolus Announces Board Appointments and Committee Changes
PremiumCompany Announcements
Evolus Announces Board Appointments and Committee Changes
7M ago
8K
EOLS
Evolus appoints Albert White to board of directors
PremiumThe Fly
Evolus appoints Albert White to board of directors
7M ago
EOLS
Evolus announces submission of PMA to U.S. FDA for two Evolysse products
PremiumThe FlyEvolus announces submission of PMA to U.S. FDA for two Evolysse products
7M ago
EOLS
Evolus launches Nuceiva or botulinum toxin type A, in Spain
Premium
The Fly
Evolus launches Nuceiva or botulinum toxin type A, in Spain
8M ago
EOLS
Evolus Shareholders Approve ESPP and Director Elections
Premium
Company Announcements
Evolus Shareholders Approve ESPP and Director Elections
8M ago
8K
EOLS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >